Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2007-10-09
2007-10-09
Kennedy, Sharon E. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C623S001420, C424S426000
Reexamination Certificate
active
10245840
ABSTRACT:
An intraluminal medical device comprises a stent having a coating applied to at least part of an interior surface, an exterior surface, or both. The coating comprises a sustained release formulation of a combination of pharmaceutical compounds dispersed within a biologically tolerated polymer composition. The choice of the combination of pharmaceutical compounds are intended to reduce neointimal hyperplasia restenosis.
REFERENCES:
patent: 4650803 (1987-03-01), Stella et al.
patent: 5464650 (1995-11-01), Berg et al.
patent: 5624411 (1997-04-01), Tuch
patent: 5972027 (1999-10-01), Johnson
patent: 6051576 (2000-04-01), Grazyna
patent: 6639014 (2003-10-01), Pathak et al.
patent: 2003/0118528 (2003-06-01), Walters et al.
patent: 0 623 354 (1994-11-01), None
patent: WO95/20567 (1995-08-01), None
patent: WO91/12779 (1991-09-01), None
patent: WO93/06792 (1993-04-01), None
patent: WO96/32907 (1996-10-01), None
patent: WO 02/087586 (2002-11-01), None
Ingrams D. R.: “Slow-Release 5-Fluorouracil and Triamcinolone Reduces Subglottic Stenosis in a Rabbit Model” Annals of Otology, Rhinology and Laryngology, Annals Publ., St. Louis, MO, US; vol. 109, No. 4, Apr. 2000, pp. 422-424.
Lin et al.: “(o-andp-Nitrobenzyloxycarbonyl)-5-fluorouracil Derivatives as Potential Conjugated Bioreductive Alkylating Agents” Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 29, No. 1, 1986, pp. 84-89.
Double et al: “Nucleoside analogues. 5. Molecular combination of anti-cancer drugs: activity of 5-fluorouracil
itrosourea combination against mouse colon tumours” Anti-Cancer Drug Design, Basingstroke, GB, vol. 1, No. 2, 1986, pp. 133-139-140.
Ashton Paul
Chen Jianbing
Fish & Neave IP Group Ropes & Gray LLP
Psivida Inc.
LandOfFree
Stent coated with a sustained-release drug delivery and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stent coated with a sustained-release drug delivery and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stent coated with a sustained-release drug delivery and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3899447